share_log

Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket

Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket

為什麼 Celyad 腫瘤學的交易價格超過 31%;這裡有 29 隻股票移動預售市場
Benzinga Real-time News ·  2022/08/01 18:45
Gainers
贏家
MAIA Biotechnology, Inc. (NASDAQ:MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00 per share. Aethlon Medical, Inc. (NASDAQ:AEMD) rose 33% to $1.33 in pre-market trading after dropping over 7% on Friday. GeoVax Labs, Inc. (NASDAQ:GOVX) rose 32.2% to $3.61 in pre-market trading amid continued strength in monkeypox names. The company also recently announced the publication of a peer-reviewed animal efficacy study of its modified vaccine Ankara vectored vaccine against Sudan ebolavirus. Celyad Oncology SA (NASDAQ:CYAD) rose 31.5% to $2.29 in pre-market trading after...
Maia生物技術公司納斯達克(Sequoia Capital:MAIA)週五大漲30%後,盤前交易中上漲37.9%,至8.00美元。該公司同意最初以每股5澳元的價格向公眾發行200萬股。 埃斯隆醫...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論